Health Catalyst, Inc. (HCAT), a provider of data and analytics technology for healthcare organizations, Tuesday announced it has repurchased approximately $5 million worth of its common stock.
The shares were acquired between March 3 and March 10, 2025, under the company's existing $40 million share repurchase program authorized in August 2022. This latest move retired approximately 1.1 million shares.
HCAT is currently trading at $4.01, up $0.03 or 0.77 percent on the Nasdaq.
For comments and feedback: editorial@rttnews.com